Challenges in Diagnosing Post-COVID Pneumonia in Kazakhstan – The Role of Point-of-Care Testing: A Letter to the Editor

نویسندگان
Ablakimova, Nurgul ID 1
Mussina, Aigul ID 2
Sakhanova, Svetlana ID 3
Kozhantayeva, Sarkyt ID 4
De Silva, Heshan Radeesha ID 5
Rachina, Svetlana ID 6
Smagulova, Gaziza ID 7
Smagulova, Daniya ID 8

1 Department of Pharmacology, Clinical Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

2 Department of Pharmacology, Clinical Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

3 Department of Pharmacology, Clinical Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

4 Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

5 Department of Otolaryngology and Ophthalmology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

6 Department of Hospital Pharmacy, Regional Perinatal Center, Aktobe, Kazakhstan

7 Hospital Therapy Department No. 2, I.M.Sechenov First Moscow State Medical University, Moscow, Russia

8 Scientific and Practical Center, Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

doi
10.30476/ijms.2025.105571.3939
چکیده

Community-acquired pneumonia (CAP) remains a major public health challenge worldwide.

کلیدواژه‌ها
Community-acquired pneumonia, adult, Polymerase chain reaction, Point-of-Care Testing